Skip to content

Clinical efficacy and microecological study of external application of ozone in the treatment of axillary osmidrosis

Clinical efficacy and microecological study of external application of ozone in the treatment of axillary osmidrosis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037275
Enrollment
Unknown
Registered
2020-08-27
Start date
2017-12-31
Completion date
Unknown
Last updated
2020-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

axillary osmidrosis

Interventions

Healthy subjects :No Intervention
Patient:acidified aliphatic ester

Sponsors

The Third Xiangya Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
11 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Aged 11 to 45 years old, male or female; 2. Patients who were diagnosed as axillary osmidrosis by clinical examination and voluntarily participated in this clinical trial; 3. No acute or chronic inflammation and infectious diseases in the axillary region; 4. Patients with axillary osmidrosis were not smeared with any drugs within two weeks before seeing a doctor.

Exclusion criteria

Exclusion criteria: 1. Patients with serious medical diseases; 2. Pregnant and lactating women; 3. Those who are allergic to acidified fatty acid esters; 4. Patients who have received surgical treatment of axillary osmidrosis (including laser) and scars in the axillary area within one year; 5. Long-term history of adverse drugs, history of drug addiction, patients with neuropsychiatric disorders; 6. Apply any topical or deodorant drugs to treat axillary odor within two weeks.

Design outcomes

Primary

MeasureTime frame
Odor assessment;Microecological;pH value;

Countries

China

Contacts

Public ContactJianyun Lu

The Third Xiangya Hospital, Central South University

xiaoyun3@csu.edu.cn+86 731 88618936

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 17, 2026